U.S. federal trademark · Serial No. 97079663
Pharmaceutical agents that target DNA structure to treat various diseases, namely, monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.